Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
Effect of coffee consumption on non-alcoholic fatty liver disease incidence, prevalence and risk of significant liver fibrosis: systematic review with meta-analysis of observational studies
NICE guideline NG28 recommends GLP-1 receptor agonists for adults with type 2 diabetes who have a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity, or a BMI lower than 35 kg/m where insulin therapy would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities
doi: 10.1097/FJC.0000000000001299 108 De BlockCBaileyCWyshamCHemmingwayAAllenSEPeleshokJ
Your diabetes may be under control with metformin, but your doctor could suggest Ozempic if you have heart disease or need to lose weight
This affects how quickly food moves through the stomach, which can cause nausea or digestive discomfort